The main prognostic factors and why minimal residual disease is becoming crucial in multiple myeloma
The work of ERIC, the European Research Initiative on CLL
The progress of CLL research: towards targeted therapy
Mimetics: the future of AML treatment?
Using cell mass to determine response to treatment: A possible cure?